Status:

RECRUITING

Artificial Intelligence for Screening of Multiple Corneal Diseases

Lead Sponsor:

Tianjin Eye Hospital

Conditions:

Deep Learning

Corneal Disease

Eligibility:

All Genders

Brief Summary

This study developed a deep learning algorithm based on anterior segment images and prospectively validated its ability to identify corneal diseases.The effectiveness and accuracy of this algorithm wa...

Eligibility Criteria

Inclusion

  • The quality of slit-lamp images should clinical acceptable.
  • More than 90% of the slit-lamp image area including three main regions (sclera, pupil, and lens) are easy to read and discriminate.

Exclusion

  • 1)Insufficient information for diagnosis.

Key Trial Info

Start Date :

December 6 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 6 2024

Estimated Enrollment :

3000 Patients enrolled

Trial Details

Trial ID

NCT06211218

Start Date

December 6 2020

End Date

December 6 2024

Last Update

November 4 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tiajin Eye Hospital

Tianjin, Tianjin Municipality, China

Artificial Intelligence for Screening of Multiple Corneal Diseases | DecenTrialz